Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
New Zealand’s success against virus counts against trial involvement
+News
New Zealand’s success against virus counts against trial involvement
Wednesday 6 May 2020, 10:05 AM

Richard Beasley, director of the Medical Research Institute of New Zealand
“Probably the biggest issue in New Zealand at the moment is how to run a trial when there are no cases. They may not be able to happen if we keep supp
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Ussher J, Le Gros G, Quinones ME, et al. The case for New Zealand to have its own COVID-19 vaccine programme. NZ Med J 2020;133,1513:112–115.
2. Rathi S, Ish P, Kalantri A, et al. Hydroxychloroquine prophylaxis for COVID-19 contacts in India. Lancet Infect Dis 2020, online 17 April.
https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30313-3.pdf